Common P-glycoprotein ( < em > ABCB1 < /em > ) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events: Preliminary data

CONCLUSIONS: The evaluated common ABCB1 polymorphisms do not seem to affect the risk of early bleeding in patients started on rivaroxaban.PMID:38665866 | PMC:PMC11042566 | DOI:10.11613/BM.2024.020703

Source: Biochemia Medica - April 26, 2024 Category: Biochemistry Authors: Ana Marija Sli šković Jozefina Pali ć Tamara Bo žina Lana Ganoci Majda Vrki ć Kirhmajer Vladimir Trkulja Jo ško Bulum Livija Šimičević Source Type: research